GDNF/GRFA1/RET MULTICOMPONENT RECEPTOR DYSFUNCTIONS IN HIRSCHSPRUNG`S DISEASE
- 2 Anni 1999/2001
- 103.291€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 2003 CANCER RESEARCH
PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting
- 2006 AMERICAN JOURNAL OF PATHOLOGY
The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease
- 2006 CELLULAR SIGNALLING
RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism
- 2006 CANCER RESEARCH
RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B
- 2006 MOLECULAR ENDOCRINOLOGY
A novel activating mutation in the RET tyrosine kinase domain mediates neoplastic transformation
